NCT02887495已完成不适用
The Scleroderma Biorepository and Pathogenesis Study (STOP Scleroderma)
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 600
- 试验地点
- 1
- 主要终点
- Modified Rodnan Skin Score
研究概览
简要总结
The Scleroderma bioreposiTOry and Pathogenesis Study (STOP Scleroderma) will help researchers use clinical data and human biospecimens to investigate why scleroderma patients develop certain complications from their disease. Patients with confirmed scleroderma, raynauds or positive autoantibodies are invited to participate. This research may help us understand how to prevent and treat scleroderma and other diseases.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 100 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Age >18 years
- •Able to give informed consent.
- •Diagnosed with scleroderma or with positive autoantibodies
排除标准
- •< 18 years old
结局指标
主要结局
Modified Rodnan Skin Score
时间窗: 10 years
次要结局
- Medsger Severity Score(10 years)
研究者
Victoria Shanmugam, MD
Professor
George Washington University
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Morbidity and Mortality Follow Up for the Scleroderma Lung StudySclerodermaNCT01762449Duke University158
已完成
不适用
Scleroderma Patient-centered Intervention Network (SPIN) Hand ProgramSystemic SclerosisSclerodermaNCT03419208Lady Davis Institute466
招募中
不适用
Scleroderma Registry & Repository at the Hospital for Special SurgerySclerodermaNCT01656447Hospital for Special Surgery, New York300
Unknown
不适用
Pragmatic Clinical Trials in SclerodermaScleroderma, SystemicSclerosis, SystemicNCT03610217University of West London400
已完成
1 期
Treatment of Refractory Sever Systemic Scleroderma by Injection of Allogeneic Mesenchymal Stem CellsSYSTEMIC SCLERODERMAALLOGENEIC MESENCHYMAL STEM CELLSADULTNCT02213705Assistance Publique - Hôpitaux de Paris20